Brad C. Dunlap and Gerald N. Kieft, analysts for Makefield Securities Corporation and authors of the report, commented, “We are excited about HDI’s transition from a development stage company into an operating company. Any reasonable success in the commercial launch of the CVProfilor® DO-2020 System should capture the attention of the investment community.” 

Makefield Securities Corporation, founded in 1984, is a Florida-based broker/dealer established to provide institutional clearing and retail brokerage services for sophisticated investors.

HDI did not prepare this research analyst report. HDI does not approve or disapprove of the contents of this report. Further, the report may not be complete or accurate, and, therefore, investors should not rely on statements contained in it. Investors should make their own investigation of HDI’s prospects before determining whether to purchase HDI securities.

Hypertension Diagnostics, Inc. designs, develops, manufactures and markets proprietary cardiovascular profiling systems for medical applications and clinical research. These systems are marketed to physicians, other health care professionals and researchers by a direct sales force and via distributors throughout the world. In addition to providing blood pressure values, the systems non-invasively detect subtle changes in the compliance or elasticity of both large and small arteries which is a unique feature of HDI’s technology.
Forward-looking statements in this press release are made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The Company wishes to caution readers not to place undue reliance on any forward-looking statements and to recognize that the statements are not a prediction of actual future results. Actual results could differ materially from those presented and anticipated in the forward-looking statements due to the risks and uncertainties set forth in the Company’s 2000 Annual Report on Form 10-KSB, as amended, under the caption “Risk Factors,” as well as others not now anticipated.

CVProfilor is a registered trademark of Hypertension Diagnostics, Inc.
  
Hypertension Diagnostics, HDI/PulseWave, PulseWave and CVProfile are trademarks of Hypertension Diagnostics, Inc. All rights reserved.

Investor Relations: Jens Dalsgaard and Tony Altavilla,
Managing Directors
Redwood Consultants, LLC
Mill Valley, CA 94941
415-380-0500

Contact: Greg H. Guettler, President